Dolby Laboratories - DLB Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DLB shares.
View DLB analyst ratings or view top-rated stocks.

3 brokers have issued 1-year target prices for Dolby Laboratories' stock. Their DLB share price forecasts range from $90.00 to $116.00. On average, they expect the company's stock price to reach $98.67 in the next year. This suggests a possible upside of 19.1% from the stock's current price.
View analysts price targets for DLB or view top-rated stocks among Wall Street analysts.

Dolby Laboratories' stock was trading at $70.54 at the beginning of 2023. Since then, DLB shares have increased by 17.4% and is now trading at $82.83.
View the best growth stocks for 2023 here.

Dolby Laboratories saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 1,030,000 shares, an increase of 17.9% from the February 13th total of 873,700 shares. Based on an average daily trading volume, of 379,700 shares, the short-interest ratio is presently 2.7 days. Currently, 1.7% of the shares of the stock are short sold.
View Dolby Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our DLB earnings forecast.

Dolby Laboratories, Inc. (NYSE:DLB) announced its earnings results on Tuesday, November, 16th. The electronics maker reported $0.58 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.02. The electronics maker earned $285.03 million during the quarter, compared to the consensus estimate of $299.95 million. Dolby Laboratories had a net margin of 14.83% and a trailing twelve-month return on equity of 9.46%. Dolby Laboratories's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.28 earnings per share.

Dolby Laboratories announced a quarterly dividend on Thursday, February 2nd. Stockholders of record on Tuesday, February 14th will be given a dividend of $0.27 per share on Wednesday, February 22nd. This represents a $1.08 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Monday, February 13th.
Read our dividend analysis for DLB.

ETFs with the largest weight of Dolby Laboratories (NYSE:DLB) stock in their portfolio include LeaderShares AlphaFactor Tactical Focused ETF (LSAT), ProShares S&P Technology Dividend Aristocrats ETF (TDV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Fount Metaverse ETF (MTVR), WisdomTree U.S. Multifactor Fund (USMF), Vanguard U.S. Minimum Volatility ETF (VFMV), American Century Low Volatility ETF (LVOL) and iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV).

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.08 per share and currently has a dividend yield of 1.31%. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 58.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 38.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

Dolby Laboratories updated its second quarter earnings guidance on Thursday, February, 2nd. The company provided earnings per share guidance of $0.90-$1.05 for the period, compared to the consensus earnings per share estimate of $0.93. The company issued revenue guidance of $340-$370 million, compared to the consensus revenue estimate of $332.11 million.

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (4.56%), Clearbridge Investments LLC (3.03%), Ninety One UK Ltd (2.42%), Mackenzie Financial Corp (1.56%), Wells Fargo & Company MN (1.23%) and Jackson Square Partners LLC (1.20%). Insiders that own company stock include Anjali Sud, Avadis Tevanian, Emily Rollins, Giles Baker, John D Couling, Kenneth D Knight, Kevin J Yeaman, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Peter C Gotcher, Peter C Gotcher, Ryan Nicholson, Simon Segars, Steven E Forshay, Steven E Forshay and Todd Pendleton.
View institutional ownership trends.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DLB stock can currently be purchased for approximately $82.83.

Dolby Laboratories (NYSE:DLB) has a market capitalization of $7.94 billion and generates $1.25 billion in revenue each year. The electronics maker earns $184.09 million in net income (profit) each year or $1.85 on an earnings per share basis.

The company employs 2,336 workers across the globe.

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for the company is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at investor@dolby.com, or via fax at 415-645-4000.